Clene Inc. financial data

Symbol
CLNN, CLNNW on Nasdaq
Industry
Pharmaceutical Preparations
Location
6550 South Millrock Drive, Suite G50, Salt Lake City, UT
State of incorporation
DE
Fiscal year end
December 31
Former names
Chelsea Worldwide Inc. (to 12/18/2020)
Latest financial report
10-K - Q4 2024 - Mar 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 108 % -58.1%
Quick Ratio 0.31 % -31.5%
Debt-to-equity -1.66K % -649%
Return On Equity 1.71K %
Return On Assets -109 % -21.6%
Operating Margin -9.68K % -56.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.59M shares -93.3%
Common Stock, Shares, Outstanding 8.09M shares +26%
Entity Public Float 36M USD -53.9%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 6.95M shares +32.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 342K USD -47.7%
Cost of Revenue 70K USD -42.1%
Research and Development Expense 20.1M USD -24.8%
General and Administrative Expense 13.3M USD -7.71%
Costs and Expenses 33.4M USD -18.8%
Operating Income (Loss) -33.1M USD +18.4%
Nonoperating Income (Expense) -6.31M USD +29.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -39.4M USD +20.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -39.4M USD +20.4%
Earnings Per Share, Basic -5.67 USD/shares +39.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.2M USD -57.8%
Marketable Securities, Current 0 USD -100%
Cash, Cash Equivalents, and Short-term Investments 12.2M USD -65.1%
Accounts Receivable, after Allowance for Credit Loss, Current 64K USD -55.2%
Inventory, Net 68K USD +83.8%
Other Assets, Current 137K USD -75.9%
Assets, Current 16.2M USD -58.4%
Operating Lease, Right-of-Use Asset 3.64M USD -12.6%
Assets 27.3M USD -47.8%
Accounts Payable, Current 1.24M USD -17.6%
Accrued Liabilities, Current 7.77M USD +109%
Liabilities, Current 10.3M USD -59.4%
Operating Lease, Liability, Noncurrent 4.13M USD -15.7%
Liabilities 36.2M USD -7.08%
Accumulated Other Comprehensive Income (Loss), Net of Tax 71K USD -64.3%
Retained Earnings (Accumulated Deficit) -282M USD -16.2%
Stockholders' Equity Attributable to Parent -8.86M USD -166%
Liabilities and Equity 27.3M USD -47.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.08M USD +23.2%
Net Cash Provided by (Used in) Financing Activities -19K USD -100%
Net Cash Provided by (Used in) Investing Activities 71K USD -98.5%
Common Stock, Shares Authorized 600M shares +100%
Common Stock, Shares, Issued 8.09M shares +26%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.09M USD -6545%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12.2M USD -57.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 784K USD -20.2%
Deferred Tax Assets, Valuation Allowance 65.9M USD +14.9%
Operating Lease, Liability 5.06M USD -7.68%
Depreciation 1.65M USD -3.52%
Payments to Acquire Property, Plant, and Equipment 11K USD -96%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -39.5M USD +20.2%
Lessee, Operating Lease, Liability, to be Paid 6.53M USD -12.3%
Operating Lease, Liability, Current 926K USD +60.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.24M USD +2.32%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.37M USD +27%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.47M USD -25.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.13M USD -8.33%
Deferred Tax Assets, Operating Loss Carryforwards 40.7M USD +15.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.09M USD -3.45%
Operating Lease, Payments 307K USD +1.32%
Additional Paid in Capital 273M USD +6.75%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 7.95M USD -12.8%
Interest Expense 4.74M USD +32.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%